KEYNOTE-006 Study Of Pembrolizumab (pembro) Versus Ipilimumab (ipi) For Advanced Melanoma: Efficacy By PD-L1 Expression And Line Of Therapy.
Adil Daud, Christian U. Blank, Caroline Robert, Igor Puzanov, Erika Richtig, Kim Allyson Margolin, Steven O'Day, Marta Nyakas, Jose Lutzky, Ahmad A. Tarhini, Elaine McWhirter, Christian Caglevic, Peter Mohr, Michael Millward, Marcus O. Butler, Honghong Zhou, Kenneth Emancipator, Scot Ebbinghaus, Nageatte Ibrahim, Georgina V. Long
Twitter
Facebook
LinkedIn
Email